Rigel Pharmaceuticals (RIGL) Is Up 20.5% After Global VEPPANU Rights Deal With Pfizer, Arvinas - Has The Bull Case Changed?
Pfizer Inc PFE
$25.96
▲ +0.35%
(+$0.09)
Index member:
S&P 500
Open
$25.80
Prev Close
$25.87
Day Range
$25.64 – $26.09
52W Range
$21.97 – $28.75
Market Cap
$147.44B
P/E (TTM)
19.66
Beta
0.30
Div Yield
6.63%
EPS (TTM)
$1.31
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1944-01-17 |
| Shares Out. | 5,688,360,000 |
| Website | pfizer.com/ ↗ |
| Phone | 12127332323 |
Pfizer Inc is a publicly traded company under the ticker symbol PFE on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
36 analysts (2026-05-01)
📰 Latest News for PFE
Top Analyst Reports for Meta, Pfizer & Salesforce
TIME Names California Water Service Group One of the World’s Most Impactful Companies
Valneva Q1 Earnings Call Highlights
These Analysts Increase Their Forecasts On Arvinas After Q1 Results
Transcript: Valneva Q1 2026 Earnings Conference Call
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
3 Struggling Stocks That Could Make for Great Contrarian Buys